Top F.D.A. Official Resigns Under Pressurenews2025-07-30T02:59:00+00:00July 30th, 2025|The New York Times|
RFK Jr. Announces Plan to Restrict Opioid-Like Kratom Productnews2025-07-29T17:58:54+00:00July 29th, 2025|The New York Times|
UnitedHealth Grew to Be a Leviathan. Then Came the Backlash.news2025-07-28T14:47:45+00:00July 28th, 2025|The New York Times|
Trump Administration’s N.I.H. and F.D.A. Cuts Could Curtail New Drug Development, Budget Office Saysnews2025-07-18T16:08:45+00:00July 18th, 2025|The New York Times|
F.D.A. Posts Collection of Letters Outlining Concerns About New Drugsnews2025-07-10T21:42:29+00:00July 10th, 2025|The New York Times|
What to Know About the Collapse of the F.D.A.news2025-07-08T09:01:49+00:00July 8th, 2025|The New York Times|
Drugmakers Notch a $5 Billion Win in Republicans’ Policy Billnews2025-07-03T19:02:53+00:00July 3rd, 2025|The New York Times|
Top F.D.A. Official Overrode Scientists on Covid Shotsnews2025-07-02T20:07:24+00:00July 2nd, 2025|The New York Times|
Texas OK’s $50 Million for Ibogaine Researchnews2025-06-14T19:18:02+00:00June 14th, 2025|The New York Times|